Paediatric tuberculosis in Europe: Lessons from Denmark and inclusive strategies to consider

European Respiratory Journal

Volumn 43, Issue 3, 2014, Pages 678-684

  Marais, Ben J ^a   Tadolini, Marina ^b   Zignol, Matteo ^c   Migliori, Giovanni Battista ^c  

^a University of Sydney   (Australia)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TRANSMISSION; DENMARK; EUROPE; EXTRAPULMONARY TUBERCULOSIS; HERD IMMUNITY; HUMAN; IMMIGRANT; INCIDENCE; INFECTION RISK; INTEGRATIVE MEDICINE; INTERFERON GAMMA RELEASE ASSAY; LUNG TUBERCULOSIS; MILIARY TUBERCULOSIS; MULTIDRUG RESISTANT TUBERCULOSIS; PRIORITY JOURNAL; REVIEW; TUBERCULIN TEST; TUBERCULOSIS; TUBERCULOSIS CONTROL; TUBERCULOUS MENINGITIS;

FEMALE; HUMANS; MALE; TUBERCULOSIS; TUBERCULOSIS, PULMONARY;

EID: 84895547297     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00133613     Document Type: Review

References (36)

1. Perez-Velez CM, Marais BJ. Tuberculosis in children. N Engl J Med 2012; 367: 348-361.
2. Marais B, Graham S, Maeurer M, et al. Progress and challenges in childhood tuberculosis. Lancet Infect Dis 2013; 13: 287-289.
3. World Health Organization. Global tuberculosis report 2012. www.who.int/tb/publications/global-report/en/index. html
4. Hill PC, Rutherford ME, Audas R, et al. Closing the policy-practice gap in the management of child contacts of tuberculosis in developing countries. PLoS Med 2011; 8: e10001105.
5. Hatleberg CI, Prahl JB, Rasmussen JN, et al. A review of paediatric tuberculosis in Denmark: 10-year trend, 2000-2009. Eur Respir J 2014; 43: 863-871.
6. Sandgren A, Hollo V, Quinten C, et al. Childhood tuberculosis in the European Union/European Economic Area, 2000 to 2009. Euro Surveill 2011; 16: 12.
7. Marais BJ, Gie RP, Schaaf HS, et al. A proposed radiologic classification of childhood intra-thoracic tuberculosis. Pediatr Rad 2004; 33: 886-894.
8. Marais BJ, Gie RP, Schaaf HS, et al. Childhood pulmonary tuberculosis-old wisdom and new challenges. Am J Respir Crit Care Med 2006; 173: 1078-1090.
9. ptbnet. www.tb-net.org/index.php/ptbnet Date last accessed: September 25, 2013.
10. Sandgren A, Cuevas LE, Dara M, et al. Childhood tuberculosis: progress requires an advocacy strategy now. Eur Respir J 2012; 40: 294-297.
11. Nejat S, Buxbaum C, Eriksson M, et al. Pediatric tuberculosis in Stockholm: a mirror to the world. Pediatr Infect Dis J 2012; 31: 224-227.
12. Nelson LJ, Wells CD. Global epidemiology of childhood tuberculosis. Int J Tuberc Lung Dis 2004; 8: 636-647.
13. van der Werf MJ, Blasi F, Giesecke J, et al. Lessons learnt in Europe on tuberculosis surveillance, outbreaks and BCG vaccination in 2011. Eur Respir J 2013; 41: 767-771.
14. Dara M, Acosta CD, Rusovich V, et al. Bacille Calmette-Guérin vaccination: the current situation in Europe? Eur Respir J 2014; 43: 24-35.
15. Diel R, Goletti D, Ferrara G, et al. Interferon-c release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur Respir J 2011; 37: 88-99.
16. Migliori GB, Zellweger JP, Abubakar I, et al. European Union standards for tuberculosis care. Eur Respir J 2012; 39: 807-819.
17. Weyer K, Mirzayev F, Migliori GB, et al. Rapid molecular TB diagnosis: evidence, policy making and global implementation of Xpert MTB/RIF. Eur Respir J 2013; 42: 252-271.
18. Graham SM, Ahmed T, Amanullah F, et al. Evaluation of tuberculosis diagnostics in children: 1. proposed clinical case definitions for classification of intrathoracic tuberculosis disease. Consensus from an expert panel. J Infect Dis 2012; 205: Suppl. 2, S199-S208.
19. Marais BJ, Hesseling AC, Gie RP, et al. Bacteriologic yield in children with intra-thoracic tuberculosis. Clin Infect Dis 2006; 42: e69-e71.
20. Abubakar I, Ford N, Cox H, et al. The rising tide of drug-resistant tuberculosis-time for visionary leadership. Lancet Infect Dis 2013; 13: 529-539.
21. Zignol M, Sismanidis C, Falzon D, et al. Multidrug-resistant tuberculosis in children: evidence from global surveillance. Eur Respir J 2013; 42: 701-707.
22. Jenkins HE, Plesca V, Ciobanu A, et al. Assessing spatial heterogeneity of MDR-TB in a high burden country. Eur Respir J 2013; 42: 1291-1301.
23. Ettehad D, Schaaf HS, Seddon J, et al. Treatment outcomes for children with multi-drug resistant tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis 2012; 12: 449-456.
24. Blasi F, Dara M, van der Werf MJ, et al. Supporting TB clinicians managing difficult cases: the ERS/WHO Consilium. Eur Respir J 2013; 41: 491-494.
25. van der Werf MJ, Langendam MW, Sandgren A, et al. Lack of evidence to support policy development for management of contacts of multidrug-resistant tuberculosis patients: two systematic reviews. Int J Tuberc Lung Dis 2012; 16: 288-296.
26. Williams B, Ramroop S, Shah P, et al. Management of pediatric contacts of multidrug resistant tuberculosis in the United Kingdom. Pediatr Infect Dis J 2013; 32: 926-927.
27. Marais BJ, Ayles H, Graham SM, et al. Screening and preventive therapy for tuberculosis. Chest Clin N Am 2009; 30: 827-846.
28. Diel R, Loddenkemper R, Zellweger JP, et al. Old ideas to innovate tuberculosis control: preventive treatment to achieve elimination. Eur Respir J 2013; 42: 785-801.
29. Blasi F, Barnes PJ, Gaga M, et al. Future Directions for the ERS: presidential plans. Eur Respir J 2013; 42: 875-880.
30. Koser CU, Bryant JM, Becq J, et al. Whole-genome sequencing for rapid susceptibility testing of M. tuberculosis. N Engl J Med 2013; 369: 290-292.
31. Marais BJ. Tuberculosis in children. Ped Pulmonol 2008; 43: 322-329.
32. Lönnroth K, Castro KG, Chakaya JM, et al. Tuberculosis control and elimination 2010-50: cure, care, and social development. Lancet 2010; 375: 1814-1829.
33. Getahun H, Sculier D, Sismanidis C, et al. Prevention, diagnosis, and treatment of tuberculosis in children and mothers: evidence for action for maternal, neonatal, and child health services. J Infect Dis 2012; 205: Suppl. 2, S216-S227.
34. Marais B, Lönnroth K, Lawn S, et al. Tuberculosis co-morbidity with communicable and non-communicable diseases: integrating health services and control efforts. Lancet Infect Dis 2013; 13: 436-448.
35. Keshavjee S, Farmer PE. Tuberculosis, drug resistance and the history of modern medicine. N Engl J Med 2012; 36: 931-936.
36. Kim JY, Farmer P, Porter M. Redefining global health-care delivery. Lancet 2013; 382: 1060-1069.